Violet is playing an important role in the wider normalisation of death and dying, destigmatising necessary conversations and bringing down barriers that stop people from seeking support.
In the same way that attitudes towards mental health have been transformed, Violet strives to effect the same change around the last stage of life.
By Violet CEO Melissa Reader, Prof Kathy Eagar, Director of the Australian Health Services Research Institute and clinical committee members Prof. Ken Hillman, AO and Dr. Leeroy William.
Read the full article on the Medical Journal of Australia Insight+